EN DE
Watch Solesence, Inc. Common Stock for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Solesence, Inc. (SLSN) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Solesence, Inc. stock $0.43, price $0.86, that is 50.0% below the price, quality 30 out of 100. Rating: strongly overvalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive US

SI Solesence, Inc. logo Thin data Nov 8, 2026

Solesence, Inc.

SLSN · US
Very expensive, weak quality

Our calculation puts a fair price 50% below what the stock costs today.

Expensive Growth (revenue 3y +18.5 %/yr in USD)
Loss over the last twelve months · -5.3% net margin (TTM) · fiscal year 2025 2.9%
Moderate debt
Revenue last quarter 25% below a year ago.
Fair value $0.4300 · Strongly overvalued
Quality 30/100
Negative free cash flow
Trails peers (1/10)
Narrow moat 17/100 · thin data
Thin data
Watch Solesence, Inc. Common Stock for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$5.21 $0.6400 Fair Value $0.4300 Apr 2025 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.

How to read this chart

19‑month range $0.6400 – $5.21 · fair‑value band $0.3200 – $0.5400 · the $0.8600 price screens above the $0.4300 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.

Follow Solesence, Inc. Common Stock in your weekly email

Every Wednesday you see whether Solesence, Inc. Common Stock is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients.

Show moreShow less

It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products.

The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. It serves skin health, beauty, and wellness sectors.

The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.

Stock analysis

Solesence, Inc. (SLSN) currently trades at $0.8600, while our model-based Fair Value estimate is $0.4300, 50% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of $0.6500 per share, and 1 of the 12 models we run sit above the $0.8600 price.

Bear case: the Economic Profit group reads lowest at $0.1050, and 11 of the 12 models stay below the price. Data coverage for this calculation is low.

Scenario range: $0.3200 (bear) to $0.5400 (bull), the price of $0.8600 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 30/100 (below-average quality), in the Consumer Defensive sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Solesence, Inc. Common Stock reported revenue of $62.1M in FY2025 versus $29.5M in FY2021, a compound +20.5%/yr. Reported net income was $1.8M in FY2025, compounding −6.3%/yr from FY2021.

Key figures

Market cap $67.1M Micro · P/S ratio 1.21 · EPS (TTM) $−0.0400 · Net margin −5.3% · Return on equity −18.6% · Return on assets (EBIT) 1.0% (5-year average) · Operating margin 0.8% · Revenue (TTM) $55.4M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 17 out of 100 (low confidence).

What moves the price

The share trades about 72% below its 52-week high and 34% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −26% fair-value upside, at −50%, SLSN screens richer than that median.

Fair Value models

Bear $0.3200 Fair Value $0.4300 Bull $0.5400
Price $0.8600 · Downside -50.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV n/a $0.0100 $0.0200 68
Residual Income $0.1900 $0.2000 $0.2200 68
ROIC Compounder n/a $0.0100 $0.0200 65
All 14 models by family
Earnings-Based
Graham-Dodd $0.1700 $1.20 $1.69 60
Lynch FV $0.3700 $0.5200 $0.6800 58
PEG = 1.0 $0.3700 $0.5200 $0.6800 55
EPV n/a $0.0100 $0.0200 68
Multiples
P/E Multiple $0.3200 $0.4300 $0.5400 63
P/S Multiple $0.3200 $0.4300 $0.5400 58
P/B Multiple $0.5600 $0.7500 $0.9400 55
EV/EBIT n/a n/a $0.0600 61
EV/EBITDA n/a $0.0200 >$0.0800 62
EV/Revenue n/a n/a $0.0500 50
Asset-Based
NCAV (Graham) $0.1200 $0.1700 $0.2500 54
Economic Profit
Residual Income $0.1900 $0.2000 $0.2200 68
ROIC Compounder n/a $0.0100 $0.0200 65
Growth Earnings
Growth-Adj P/E $0.4600 $0.6500 $0.8500 65

Open the full fair value analysis →

Quality Score breakdown

Overall quality 30/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 51
How much profit the company makes from its sales and capital
Quality Growth 36
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 25
Debt, balance sheet and risk of trouble
Investment 40
Does it invest with discipline instead of growing at any price?
Low Volatility 16
How calm the share price moves, does not count
Price momentum 10
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 5
Distance to the 52-week high, does not count
New shares 50
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, no officer or director bought or sold shares on the open market.

  • BuyR Janet WhitmoreDirector2× since Nov 14, 2025: 37,556 shares, avg. $1.81$68,059Dec 24, 2025

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 6, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 58/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+18.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.5%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−12.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year−12.9%
Dividend (yield on the price)0.0%
Profit margin 2021 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.9% → 3%

SLSN screens overvalued: fair value 50% below the price. Compare with Colgate-Palmolive Company →

Compare Solesence, Inc. Common Stock with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 230 stocks

Beats the industry median on 1/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 30 · Bottom 25%
Fair Value upside −50.0% · Bottom 25%
Profitability
Return on assets 3.6% · Below median
Net margin (12 months) −5.3% · Bottom 25%
Operating margin (12 months) 0.8% · Below median
Growth and dividend
Revenue growth (quarter YoY) −24.7% · Bottom 25%
Balance sheet
Debt / equity 0.60× · Highest 25%

Valuation Multiplesvs Household & Personal Products median · lower = cheaper

P/B 3.81× · Priciest 25%
P/S (12 months) 1.21× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 36
FUTURE (revenue growth)0 · sector 20
PAST (return on equity)0 · sector 31
HEALTH (low debt)70 · sector 98
DIVIDEND (yield)0 · sector 53

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Godrej Consumer Products Limited GODREJCP ₹851.00 ₹1,146 +35% vs SLSN
Puig Brands, S.A PUIG €19.84 €24.28 +22% vs SLSN
Henkel AG HEN €74.85 €82.55 +10% vs SLSN
Beiersdorf Aktiengesellschaft, BEI €85.26 €69.09 −19% vs SLSN
The Clorox Company CLX $99.96 $74.29 −26% vs SLSN
Church & Dwight Co CHD $109.33 $65.04 −41% vs SLSN
Colgate-Palmolive Company CL $96.56 $56.16 −42% vs SLSN
Marico Limited MARICO ₹897.75 ₹493.84 −45% vs SLSN
The Estée Lauder Companies Inc EL $110.06 $44.21 −60% vs SLSN
Hindustan Unilever Limited HINDUNILVR ₹1,998 ₹775.25 −61% vs SLSN

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Solesence, Inc. Common Stock: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Solesence, Inc. Common Stock Fair Value". https://www.fairvalue-calculator.com/stock/SLSN

Frequently asked questions

Is Solesence, Inc. (SLSN) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of $0.4300 versus a price of $0.8600, about 50% lower (overvalued).
What is the fair value of SLSN?
Our model-based fair value for Solesence, Inc. is $0.4300 (as of Nov 8, 2026), built from audited fundamentals. The current price: $0.8600.
What is the quality score of SLSN?
Solesence, Inc. has a Quality Score of 30/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Solesence, Inc. (SLSN)?
Our model-based price target is the fair value of $0.4300 (as of Nov 8, 2026) from 14 valuation models. Cautious scenario $0.3200, optimistic scenario $0.5400. It is a calculation from audited fundamentals, not an analyst target.
What is the Solesence, Inc. Common Stock stock forecast for 2026?
Our models put fair value at $0.4300, about 50% lower versus a price of $0.8600 (overvalued). Cautious scenario $0.3200, optimistic scenario $0.5400. The calculation is refreshed regularly with new filings.
What is the revenue of Solesence, Inc. (SLSN)?
Solesence, Inc. reported trailing-twelve-month revenue of about $55.4M (latest available figure, as of Nov 8, 2026).
What is the intrinsic value of Solesence, Inc. (SLSN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Solesence, Inc. it is $0.4300 per share (as of Nov 8, 2026), against a price of $0.8600. It is the blended result of 14 valuation models in 5 families (Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Solesence, Inc. Common Stock stock overvalued or undervalued in 2026?
As of Nov 8, 2026, SLSN trades above its calculated fair value: price $0.8600, fair value $0.4300, a gap of about −50% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SLSN?
No. The price is what the market pays today ($0.8600); the fair value is what the company's own numbers justify ($0.4300). For Solesence, Inc. the two are $0.4300 per share apart. That gap is exactly why we show both numbers side by side.
How much is Solesence, Inc. Common Stock worth?
The market values Solesence, Inc. at about $67.1M (market capitalisation, as of Nov 8, 2026). Per share that is $0.8600; our models calculate a fair value of $0.4300 per share.
What do the bullish and bearish scenarios say about SLSN?
Our models span a range for Solesence, Inc.: cautious scenario $0.3200, base $0.4300, optimistic $0.5400 per share (as of Nov 8, 2026, price $0.8600). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Solesence, Inc. (SLSN)?
Balance-sheet figures for Solesence, Inc. (as of Nov 8, 2026): return on equity −18.6%, debt of 0.60 per unit of equity. They feed the Quality Score of 30/100, which measures business quality independently of the share price.
How far is SLSN from its 52-week high?
Solesence, Inc. trades at $0.8600, about 72% below its 52-week high of $3.08 and 34% above the low of $0.6400 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $0.4300 is for.
Which stocks are comparable to Solesence, Inc. Common Stock?
From the same area (Consumer Defensive) we also value Colgate-Palmolive Company, Hindustan Unilever Limited, The Estée Lauder Companies Inc, Henkel AG, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Solesence, Inc. Common Stock stock attractive at the current price?
The data as of Nov 8, 2026: price $0.8600, calculated fair value $0.4300 (−50%), Quality Score 30/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SLSN calculated?
We run Solesence, Inc. through 14 models from 5 families: Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $0.4300 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Solesence, Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Solesence, Inc. (SLSN)?
The closing price on Nov 6, 2026 was $0.8600. Our model-based fair value is $0.4300, about 50% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Solesence, Inc. Common Stock right now?
The price sits above even our optimistic bull case ($0.5400). The favourable scenario is already priced in. Weak quality (30/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Solesence, Inc.

How large is the market capitalisation of Solesence, Inc. (SLSN)?
The market capitalisation of Solesence, Inc. is $67.1M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Solesence, Inc. (SLSN)?
The price-to-sales ratio of Solesence, Inc. is 1.21 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Solesence, Inc. (SLSN)?
Earnings per share at Solesence, Inc. are $−0.0400. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Solesence, Inc. (SLSN)?
The net margin of Solesence, Inc. is −5.3% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Solesence, Inc. (SLSN)?
The return on equity (ROE) of Solesence, Inc. is −18.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Solesence, Inc. (SLSN)?
On an EBIT basis the return on assets of Solesence, Inc. is 1.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Solesence, Inc. (SLSN)?
The operating margin of Solesence, Inc. is 0.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Solesence, Inc. (SLSN)?
Revenue at Solesence, Inc. is growing −24.7% versus a year earlier (3y avg +18.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Solesence, Inc. (SLSN)?
Earnings per share at Solesence, Inc. are growing −93.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Solesence, Inc. (SLSN) generate?
The free cash flow of Solesence, Inc. is −$10.7M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Solesence, Inc. (SLSN) carry?
The net debt of Solesence, Inc. is $23.0M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Solesence, Inc. Common Stock in the live analysis

One click puts Solesence, Inc. Common Stock on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.